Sensex
77,264.51 profit arw 330.92 (0.43%)
Nifty
24,175.65 profit arw 84.80 (0.35%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Enter a 10 digit mobile number starting with 7, 8, or 9
Captcha verification code, enter the characters shown below

As on : 26-Aug-2026
Corporate News
26-Aug-2026     20:43

Senores Pharmaceuticals expands internationally with subsidiaries in Mexico and Canada

Senores Pharmaceuticals Limited announced several strategic moves, including the appointments of Dr. Viranchi Arvindbhai Shah as Director, Shilpa Shah as Company Secretary, and Rajeev Kumar as Chief Financial Officer. The company’s board approved the Senores Pharmaceuticals Employee Stock Option Scheme 2026, granting 4,72,000 options, representing 1% of equity, to eligible employees with a potential discount of up to 50% on the market price. Furthermore, Senores Pharmaceuticals is expanding its international operations by incorporating a wholly-owned subsidiary in Mexico to distribute pharmaceutical products and establishing a subsidiary in Canada, in which it will hold at least 51% ownership, both funded through cash investments. Regulatory approvals will be obtained as required by Mexican and Canadian law.

INDIAN INDICES

Sensex

77,264.51 330.92 (0.43%)

Nifty

24,175.65 84.80 (0.35%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

25,584.80 19.05(0.07%)